427 related articles for article (PubMed ID: 15776112)
1. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
Zhuang L; Kim J; Adam RM; Solomon KR; Freeman MR
J Clin Invest; 2005 Apr; 115(4):959-68. PubMed ID: 15776112
[TBL] [Abstract][Full Text] [Related]
2. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
Zhuang L; Lin J; Lu ML; Solomon KR; Freeman MR
Cancer Res; 2002 Apr; 62(8):2227-31. PubMed ID: 11956073
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol sensitivity of endogenous and myristoylated Akt.
Adam RM; Mukhopadhyay NK; Kim J; Di Vizio D; Cinar B; Boucher K; Solomon KR; Freeman MR
Cancer Res; 2007 Jul; 67(13):6238-46. PubMed ID: 17616681
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
Li YC; Park MJ; Ye SK; Kim CW; Kim YN
Am J Pathol; 2006 Apr; 168(4):1107-18; quiz 1404-5. PubMed ID: 16565487
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains.
Cinar B; Mukhopadhyay NK; Meng G; Freeman MR
J Biol Chem; 2007 Oct; 282(40):29584-93. PubMed ID: 17635910
[TBL] [Abstract][Full Text] [Related]
8. Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor.
Oh HY; Leem J; Yoon SJ; Yoon S; Hong SJ
Biochem Biophys Res Commun; 2010 Mar; 393(2):319-24. PubMed ID: 20138837
[TBL] [Abstract][Full Text] [Related]
9. The integrity of cholesterol-enriched microdomains is essential for the constitutive high activity of protein kinase B in tumour cells.
Elhyany S; Assa-Kunik E; Tsory S; Muller T; Fedida S; Segal S; Fishman D
Biochem Soc Trans; 2004 Nov; 32(Pt 5):837-9. PubMed ID: 15494028
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.
Calay D; Vind-Kezunovic D; Frankart A; Lambert S; Poumay Y; Gniadecki R
J Invest Dermatol; 2010 Apr; 130(4):1136-45. PubMed ID: 20054340
[TBL] [Abstract][Full Text] [Related]
11. Effect of simvastatin on glioma cell proliferation, migration, and apoptosis.
Wu H; Jiang H; Lu D; Xiong Y; Qu C; Zhou D; Mahmood A; Chopp M
Neurosurgery; 2009 Dec; 65(6):1087-96; discussion 1096-7. PubMed ID: 19934968
[TBL] [Abstract][Full Text] [Related]
12. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.
Pommier AJ; Alves G; Viennois E; Bernard S; Communal Y; Sion B; Marceau G; Damon C; Mouzat K; Caira F; Baron S; Lobaccaro JM
Oncogene; 2010 May; 29(18):2712-23. PubMed ID: 20190811
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
[TBL] [Abstract][Full Text] [Related]
15. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
16. Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells.
Fedida-Metula S; Elhyany S; Tsory S; Segal S; Hershfinkel M; Sekler I; Fishman D
Carcinogenesis; 2008 Aug; 29(8):1546-54. PubMed ID: 18579561
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
Koyuturk M; Ersoz M; Altiok N
Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
[TBL] [Abstract][Full Text] [Related]
18. CaM kinase control of AKT and LNCaP cell survival.
Schmitt JM; Smith S; Hart B; Fletcher L
J Cell Biochem; 2012 May; 113(5):1514-26. PubMed ID: 22173970
[TBL] [Abstract][Full Text] [Related]
19. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
[TBL] [Abstract][Full Text] [Related]
20. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
